IFN-γ Affects Homing of Diabetogenic T Cells1
暂无分享,去创建一个
[1] Bernhard Moser,et al. Lymphocyte traffic control by chemokines , 2001, Nature Immunology.
[2] P. Rothman,et al. Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. , 2000, Diabetes.
[3] C. Mackay,et al. T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.
[4] J. Todd,et al. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. , 2000, Diabetes.
[5] J. Todd,et al. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. , 2000, Immunity.
[6] C. Caux,et al. Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis1 , 2000, The Journal of Immunology.
[7] A. Tevaarwerk,et al. Protection of Nonobese Diabetic Mice from Diabetes by Gene(s) Closely Linked to IFN-γ Receptor Loci1 , 2000, The Journal of Immunology.
[8] P. Santamaria,et al. IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes , 2000 .
[9] D. Willenborg,et al. Kinetics and Polarization of the Membrane Expression of Cytokine‐induced ICAM‐1 on Rat Brain Endothelial Cells , 2000, Journal of neuropathology and experimental neurology.
[10] F. Wong,et al. Neonatal Tumor Necrosis Factor α Promotes Diabetes in Nonobese Diabetic Mice by Cd154-Independent Antigen Presentation to Cd8+ T Cells , 2000, The Journal of experimental medicine.
[11] A. Chervonsky. Apoptotic and effector pathways in autoimmunity. , 1999, Current opinion in immunology.
[12] G. Randolph,et al. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes , 1999, Journal of leukocyte biology.
[13] T. Kawai,et al. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. , 1999, Journal of immunology.
[14] A. Yoshimura,et al. SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.
[15] C. Janeway,et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library , 1999, Nature Medicine.
[16] G. Prud’homme,et al. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein , 1999, Gene Therapy.
[17] J. Katz,et al. In Autoimmune Diabetes the Transition from Benign to Pernicious Insulitis Requires an Islet Cell Response to Tumor Necrosis Factor α , 1999, The Journal of experimental medicine.
[18] G. Pascual,et al. Modulation of PECAM-1 (CD31) Expression in Human Endothelial Cells: Effect of IFNγ and IL-10 , 1999, Journal of Vascular Research.
[19] I. Cohen,et al. The pathogenicity of islet‐infiltrating lymphocytes in the non‐obese diabetic (NOD) mouse , 1999, Clinical and experimental immunology.
[20] R. Schreiber,et al. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. , 1998, The Journal of clinical investigation.
[21] D. Sampath,et al. Patterns for RANTES Secretion and Intercellular Adhesion Molecule 1 Expression Mediate Transepithelial T Cell Traffic Based on Analyses In Vitro and In Vivo , 1998, The Journal of experimental medicine.
[22] C. Mackay,et al. The chemokine receptor CXCR3 mediates rapid and shear‐resistant adhesion‐induction of effector T lymphocytes by the chemokines IP10 and Mig , 1998, European journal of immunology.
[23] D. Hafler,et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.
[24] C. Benoist,et al. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] L. Bouwens,et al. Effect of Interferon-γ and Glucose on Major Histocompatibility Complex Class I and Class II Expression by Pancreatic β- and Non-β-Cells1 , 1997 .
[26] C. Janeway,et al. The Role of Fas in Autoimmune Diabetes , 1997, Cell.
[27] M. V. von Herrath,et al. Interferon-γ Is Essential for Destruction of β Cells and Development of Insulin-dependent Diabetes Mellitus , 1997, The Journal of experimental medicine.
[28] F. Nicoletti,et al. The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse. , 1996, Endocrinology.
[29] B. Ripley,et al. Modern Applied Statistics with S-Plus. , 1996 .
[30] H. Ruffner,et al. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. , 1996, Immunity.
[31] Xiaojian Huang,et al. Genetic Absence of γ-Interferon Delays but Does Not Prevent Diabetes in NOD Mice , 1996, Diabetes.
[32] R. Pujol-Borrell,et al. Expression of Transporter Associated With Antigen Processing–1 in the Endocrine Cells of Human Pancreatic Islets: Effect of Cytokines and Evidence of Hyperexpression in IDDM , 1996, Diabetes.
[33] J. Monaco,et al. Identification of MECL-1 (LMP-10) as the third IFN-gamma-inducible proteasome subunit. , 1996, Journal of immunology.
[34] D. Lauffenburger,et al. Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.
[35] B. Gumbiner,et al. Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.
[36] C. Janeway,et al. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells , 1996, The Journal of experimental medicine.
[37] R. Coffman,et al. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. , 1995, Science.
[38] W. Suarez-Pinzon,et al. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. , 1995, Journal of immunology.
[39] R. Flavell,et al. Class II transactivator regulates the expression of multiple genes involved in antigen presentation , 1995, The Journal of experimental medicine.
[40] D. Greiner,et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. , 1995, Journal of immunology.
[41] A. B. Lyons,et al. Determination of lymphocyte division by flow cytometry. , 1994, Journal of immunological methods.
[42] N. Sarvetnick,et al. Induction of vascular addressins and adhesion molecules in the pancreas of IFN-gamma transgenic mice. , 1994, Journal of immunology.
[43] F. Ho,et al. Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation. , 1994, Journal of clinical pathology.
[44] A. Bradley,et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.
[45] R. Zinkernagel,et al. Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.
[46] P. Bedossa,et al. Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice , 1991, Nature.
[47] P. Bedossa,et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.
[48] L. Harrison,et al. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. , 1991, The Journal of clinical investigation.
[49] N. Sarvetnick,et al. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ , 1990, Nature.
[50] C. Janeway,et al. Prevention of Diabetes in NOD Mice by Injection of Autoreactive T-Lymphocytes , 1989, Diabetes.
[51] E. Leiter,et al. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice , 1989, The Journal of experimental medicine.
[52] N. Sarvetnick,et al. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma , 1988, Cell.
[53] Linda S. Wicker,et al. NOD Idd 5 Locus Controls Insulitis and Diabetes and Overlaps the Orthologous CTLA 4 / IDDM 12 and NRAMP 1 Loci in Humans , 2000 .
[54] P. Rothman,et al. Interferon-Receptor Signaling Is Dispensable in the Development of Autoimmune Type 1 Diabetes in NOD Mice , 2000 .
[55] L. Bradley,et al. Regulation of development and function of memory CD4 subsets. , 2000 .
[56] U. Boehm,et al. Cellular responses to interferon-gamma. , 1997, Annual review of immunology.